Immunogenic oncolysis by tigilanol tiglate by Jonathan G. Pol, Manuela Lizarralde-Guerrero, Guido Kroemer

Get full text

RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome by Jonathan G. Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, Guido Kroemer

Get full text

Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity by Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, Jonathan G. Pol

Get full text

Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma by Jonathan G. Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, Guido Kroemer

Get full text

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis by Julie Le Naour, Léa Montégut, Yuhong Pan, Sarah Adriana Scuderi, Pierre Cordier, Adrien Joseph, Allan Sauvat, Valerio Iebba, Juliette Paillet, Gladys Ferrere, Ludivine Brechard, Claire Mulot, Grégory Dubourg, Laurence Zitvogel, Jonathan G. Pol, Erika Vacchelli, Pierre-Laurent Puig, Guido Kroemer

Get full text